Lactic acid bacteria developed for skin health based on the gut-skin axis (patented)
Product Name: Probiotics HY7714 SC Ingredients: Breast milk-derived lactic acid bacteria Country of Origin: South Korea Features: Screening conducted from over 5,000 strains of probiotics, selecting the strains that showed the most significant effects on skin hydration and barrier function in cell experiments. Effects and Efficacy: Skin health regulation effect of HY7714 through improvement of intestinal environment 1. Clinical Trial Content: Clinical evidence regarding the effect of HY7714 on skin aging (110 women participants) 2. Clinical Trial Content: Skin health regulation effect of HY7714 through improvement of intestinal environment (15 healthy women participants) Others: 7 academic papers, 1 patent
Inquire About This Product
basic information
Product Name: Probiotics HY7714 SC Ingredients: Breast milk-derived lactic acid bacteria Specification: 200 billion CFU/g, live bacteria Recommended Daily Amount: 10 billion CFU/g Safety: FDA, NDI, s-GRAS, Halal certification obtained Quality Control: GMP, HACCP, FSSC22000 Shelf Life: 24 months
Price range
Delivery Time
Applications/Examples of results
Products have already been launched in the United States, Taiwan, and Japan. In South Korea, 9 products are currently on sale, holding a top share in the probiotics sector focused on skin health.
catalog（1）
Download All Catalogs
Company information
Rivason Co., Ltd. is a company located in Chuo Ward, Osaka City, engaged in the sale of functional materials, contract organic synthesis, biocides, machinery export and import, sale of pharmaceutical raw materials and intermediates, sale of functional food ingredients, sale of cosmetic ingredients, overseas contract manufacturing of pharmaceuticals, and pharmaceutical business operations.